Why biotech is a boon for patients and investors

Joe Anderson, CEO of Arix Bioscience take on the future of biotech as seen in Spears article published 13th January 2020

Today we areĀ  at the forefront of a healthcare revolution, driven by advances in genetic analysis and molecular biology that are now creating real benefits for patients, says Joe Anderson

Continue reading

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH